Tansu Altıntaş
Research Subjects
Tansu Altıntaş has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Berrin Önalan
Clinic of General Surgery, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Naciye Cigdem Arslan
Department of General Surgery Istanbul Health and Technology University Istanbul Turkey
2 shared publications - Abdullah Karakaya1 shared publication
- Adnan Mesut Dede
Clinic of General Surgery Bartın State Hospital Bartın Türkiye
1 shared publication - Ahmet Ali Tuncer
AFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, ÇOCUK CERRAHİSİ ANABİLİM DALI
1 shared publication - Aziz Ocakoğlu
UNIVERSITY OF HEALTH SCIENCES, İSTANBUL HEALTH RESEARCH CENTER
1 shared publication
Latest Publications
- 26 March 2025
- Published by Academician Publishing
- p. 1-8
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları
- 26 March 2025
- Published by Academician Publishing
- p. 1-8
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları
- Open Access
- 26 March 2025
- Published by Academician Publishing
Genel Cerrahi Dersleri Üçüncü Kitap Obezite ve Endokrin Hastalıkların Cerrahi Tedavi Prensipleri
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Tansu ALTINTAŞ Tiroid Hastalıklarının Cerrahi Tedavisi Nihat GÜLAYDIN Tiroid Cerrahisine Bağlı Komplikasyonların Yönetimi Yusuf Emre AYTİN Oğuzhan Alp ÖZTÜRK Paratiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Serkan ADEMOĞLU Paratiroid Hastalıkları ve Cerrahi Tedavi Kıvılcım ORHUN ERDOĞAN Paratiroidektominin Postoperatif Komplikasyonları Mehmet Fatih EKİCİ Sürrenal Bez Yapısal Özellikleri ve Fonksiyonları Adnan Mesut DEDE Sürrenal Bez Cerrahi Hastalıkları ve Tedavileri İsa KARACA Sürrenal Bez Cerrahisine Bağlı Komplikasyonların Yönetimi Mümtaz ERAKIN Metabolik Cerrahi Fatih TÜRKOĞLU Murat ÇİLEKAR Obezitenin Tarihi Yüksel DOĞAN Obezitenin Tanımı ve Tanı Yöntemleri Mahmut APAYDIN Obezitenin Medikal Tedavisi Serdar GÖK Selvihan BEYSEL Obezite Cerrahisi ve Psikiyatri İlişkisi Mustafa Melih BİLGİ Obezite Cerrahisine Hazırlık; Anestezi Preoperatif Hazırlıklar Bilge Banu Taşdemir MECIT Obezite Cerrahisine Hazırlık – Obez Hastalarda Görülen Kardiyolojik Problemler, Preoperatif ve Postoperatif Takip Prensipleri Mehmet Hakan UZUN Serkan GÖKASLAN Obezite Cerrahisinde Ameliyat Öncesi ve Sonrasında Pulmoner Değerlendirme Şule ÇİLEKAR Obezite Cerrahisi ve Beslenme Reyhan ÇETİN Perioperatif Obezite Cerrahisinde Anestezi Prensipleri Tuba Berra Sarıtaş Obeziteye Yönelik Endoskopik İntragastrik Balon Uygulamaları Metehan AYDIN Khalig YAGUBLU Sezgin YILMAZ Obezite Cerrahi Tedavi Prensipleri Kübra ERTEKİN Mehlika BİLGİ KIRMACI Sleeve Gastrektomi Metehan AYDIN Sezgin Yılmaz Roux-N-Y Gastrik Bypass Murat ÇİLEKAR Minigastrik By-Pass (Tek Anastomozlu Gastrik By-Pass) Kenan BÜYÜKAŞIK Biliyopankreatik Diversiyon ve Duodenal Switch Murat KEĞİN Obezitenin Cerrahi/Endoskopik Tedavisi Sonrası Metabolik ve Nutrisyonel Destek Tedavisi Emre BALLI Abdullah KARAKAYA Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Radyodiagnostik Değerlendirilmesi- Perkütan İşlemler Medine BÖGE Çiğdem ÖZER GÖKASLAN Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Yönetimi Mehmet Nuri KOŞAR Obezite Cerrahisinde Revizyon Cerrahisinin Yeri Murat AKICI Çocuk ve Ergen Obezite Tedavisinde Endoskopik ve Cerrahi Yaklaşımlar Çiğdem ARSLAN ALICI Ahmet Ali TUNCER Pankreas’ın Yapısal Özellikleri ve Fonksiyonları Burak Öztop Pankreasın Endokrin Tümörleri Mehlika BİLGİ KIRMACI Esat Taylan UĞURLU Bariyatrik Cerrahi Sonrası Vücut Şekillendirme Ameliyatları Salih Kavuncu
- 26 March 2025
- Published by Academician Publishing
Open AccessGenel Cerrahi Dersleri Üçüncü Kitap Obezite ve Endokrin Hastalıkların Cerrahi Tedavi Prensipleri
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Tansu ALTINTAŞ Tiroid Hastalıklarının Cerrahi Tedavisi Nihat GÜLAYDIN Tiroid Cerrahisine Bağlı Komplikasyonların Yönetimi Yusuf Emre AYTİN Oğuzhan Alp ÖZTÜRK Paratiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Serkan ADEMOĞLU Paratiroid Hastalıkları ve Cerrahi Tedavi Kıvılcım ORHUN ERDOĞAN Paratiroidektominin Postoperatif Komplikasyonları Mehmet Fatih EKİCİ Sürrenal Bez Yapısal Özellikleri ve Fonksiyonları Adnan Mesut DEDE Sürrenal Bez Cerrahi Hastalıkları ve Tedavileri İsa KARACA Sürrenal Bez Cerrahisine Bağlı Komplikasyonların Yönetimi Mümtaz ERAKIN Metabolik Cerrahi Fatih TÜRKOĞLU Murat ÇİLEKAR Obezitenin Tarihi Yüksel DOĞAN Obezitenin Tanımı ve Tanı Yöntemleri Mahmut APAYDIN Obezitenin Medikal Tedavisi Serdar GÖK Selvihan BEYSEL Obezite Cerrahisi ve Psikiyatri İlişkisi Mustafa Melih BİLGİ Obezite Cerrahisine Hazırlık; Anestezi Preoperatif Hazırlıklar Bilge Banu Taşdemir MECIT Obezite Cerrahisine Hazırlık – Obez Hastalarda Görülen Kardiyolojik Problemler, Preoperatif ve Postoperatif Takip Prensipleri Mehmet Hakan UZUN Serkan GÖKASLAN Obezite Cerrahisinde Ameliyat Öncesi ve Sonrasında Pulmoner Değerlendirme Şule ÇİLEKAR Obezite Cerrahisi ve Beslenme Reyhan ÇETİN Perioperatif Obezite Cerrahisinde Anestezi Prensipleri Tuba Berra Sarıtaş Obeziteye Yönelik Endoskopik İntragastrik Balon Uygulamaları Metehan AYDIN Khalig YAGUBLU Sezgin YILMAZ Obezite Cerrahi Tedavi Prensipleri Kübra ERTEKİN Mehlika BİLGİ KIRMACI Sleeve Gastrektomi Metehan AYDIN Sezgin Yılmaz Roux-N-Y Gastrik Bypass Murat ÇİLEKAR Minigastrik By-Pass (Tek Anastomozlu Gastrik By-Pass) Kenan BÜYÜKAŞIK Biliyopankreatik Diversiyon ve Duodenal Switch Murat KEĞİN Obezitenin Cerrahi/Endoskopik Tedavisi Sonrası Metabolik ve Nutrisyonel Destek Tedavisi Emre BALLI Abdullah KARAKAYA Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Radyodiagnostik Değerlendirilmesi- Perkütan İşlemler Medine BÖGE Çiğdem ÖZER GÖKASLAN Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Yönetimi Mehmet Nuri KOŞAR Obezite Cerrahisinde Revizyon Cerrahisinin Yeri Murat AKICI Çocuk ve Ergen Obezite Tedavisinde Endoskopik ve Cerrahi Yaklaşımlar Çiğdem ARSLAN ALICI Ahmet Ali TUNCER Pankreas’ın Yapısal Özellikleri ve Fonksiyonları Burak Öztop Pankreasın Endokrin Tümörleri Mehlika BİLGİ KIRMACI Esat Taylan UĞURLU Bariyatrik Cerrahi Sonrası Vücut Şekillendirme Ameliyatları Salih Kavuncu
- 1 March 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (3) , 171-176
Immunohistochemical markers affecting nodal metastasis in breast cancer and imaging methods for detection of axillary lymph node metastasis
Aim Axillary lymph node metastasis (ALNM) is a prognostic determinant of breast cancer (BC) and influences the treatment decision. Our study aimed to determine the factors associated with ALNM in BC and to accurately evaluate the ALN status with imaging methods while determining the treatment modality. Methods Patients (n=417) who underwent BC surgery in our clinic were included. Patient’s axillary ultrasound (AUS), magnetic resonance imaging (MRI), 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) reports and immunohistochemical data were collected for analysis. Results ALNM was found in 59.7% (n = 249) of the patients. Invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), lymphovascular invasion, and perineural invasion were found to be associated with ALNM (p<0.001). Tumor histological type was found to be the factor affecting true/false positivity or true/false negative of AUS, MRI, 18F-FDG-PET/CT (p<0.01, p=0.012, p=0.006). Conclusion Premenopause, IDC, ILC, and the presence of LVI or PNI are factors that increase the risk of ALNM. MRI is the most reliable to accurately predict ALNM, followed by AUS and 18F-FDG-PET/CT. If the tumor type is IDC and ILC, AUS and MRI may be superior in predicting ALNM positivity. All three imaging modalities may be reliable in accurately predicting axilla negativity in other tumor types.
- 1 March 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (3) , 171-176
Immunohistochemical markers affecting nodal metastasis in breast cancer and imaging methods for detection of axillary lymph node metastasis
Aim Axillary lymph node metastasis (ALNM) is a prognostic determinant of breast cancer (BC) and influences the treatment decision. Our study aimed to determine the factors associated with ALNM in BC and to accurately evaluate the ALN status with imaging methods while determining the treatment modality. Methods Patients (n=417) who underwent BC surgery in our clinic were included. Patient’s axillary ultrasound (AUS), magnetic resonance imaging (MRI), 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) reports and immunohistochemical data were collected for analysis. Results ALNM was found in 59.7% (n = 249) of the patients. Invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), lymphovascular invasion, and perineural invasion were found to be associated with ALNM (p<0.001). Tumor histological type was found to be the factor affecting true/false positivity or true/false negative of AUS, MRI, 18F-FDG-PET/CT (p<0.01, p=0.012, p=0.006). Conclusion Premenopause, IDC, ILC, and the presence of LVI or PNI are factors that increase the risk of ALNM. MRI is the most reliable to accurately predict ALNM, followed by AUS and 18F-FDG-PET/CT. If the tumor type is IDC and ILC, AUS and MRI may be superior in predicting ALNM positivity. All three imaging modalities may be reliable in accurately predicting axilla negativity in other tumor types.
- Open Access
- 9 January 2025
- Published by Wiley in The Breast Journal
- Vol. 2025 (1) , 9487931
Evaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability
Aim: Purpose of this study is to investigate the quality and reliability of YouTube video contents on prophylactic mastectomy. Material and Methods: The search terms “prophylactic mastectomy,” “prophylactic mastectomy surgery,” “preventive surgery for breast cancer,” “risk‐reducing mastectomy,” and “prophylactic mastectomy and breast reconstruction” were searched on YouTube. The uploader, video content, length (seconds), upload date, number of days since upload date, number of views, number of comments, and likes were recorded and evaluated. Finally, the videos included in the study were evaluated using modified Quality Criteria for Consumer Health Information (DISCERN) and Global Quality Scale (GQS). Results: The total number of views of the 50 videos reviewed in the study was found as 3.674.469. The mean DISCERN score of the two observers was calculated as 3.35 ± 1, and the videos were found to be of medium reliability. The mean GQS score of all videos was 3.39 ± 0.9 and the videos were of medium quality. The researchers gave 1‐2 points (misleading) to 7 (14%) videos, 3 points (somewhat helpful) to 20 (40%) videos, 4 points (beneficial) to 16 (32%) videos, and 5 points (excellent) to 7 (14%) videos. Conclusion: In our study, we found that the videos uploaded by doctors were of good quality, the videos uploaded by health channels were of medium quality, and the videos uploaded by patients were of poor quality and misleading. The videos with health contents should be evaluated by the relevant specialists, and only useful videos should be broadcast.
- 9 January 2025
- Published by Wiley in The Breast Journal
- Vol. 2025 (1) , 9487931
Open AccessEvaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability
Aim: Purpose of this study is to investigate the quality and reliability of YouTube video contents on prophylactic mastectomy. Material and Methods: The search terms “prophylactic mastectomy,” “prophylactic mastectomy surgery,” “preventive surgery for breast cancer,” “risk‐reducing mastectomy,” and “prophylactic mastectomy and breast reconstruction” were searched on YouTube. The uploader, video content, length (seconds), upload date, number of days since upload date, number of views, number of comments, and likes were recorded and evaluated. Finally, the videos included in the study were evaluated using modified Quality Criteria for Consumer Health Information (DISCERN) and Global Quality Scale (GQS). Results: The total number of views of the 50 videos reviewed in the study was found as 3.674.469. The mean DISCERN score of the two observers was calculated as 3.35 ± 1, and the videos were found to be of medium reliability. The mean GQS score of all videos was 3.39 ± 0.9 and the videos were of medium quality. The researchers gave 1‐2 points (misleading) to 7 (14%) videos, 3 points (somewhat helpful) to 20 (40%) videos, 4 points (beneficial) to 16 (32%) videos, and 5 points (excellent) to 7 (14%) videos. Conclusion: In our study, we found that the videos uploaded by doctors were of good quality, the videos uploaded by health channels were of medium quality, and the videos uploaded by patients were of poor quality and misleading. The videos with health contents should be evaluated by the relevant specialists, and only useful videos should be broadcast.
- Open Access
- 27 May 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (3) , 337-340
Relationship between pelvic floor complaints and multicompartment prolapsus
Aims: The aim of this study is to investigate the frequency and characteristics of multi-compartment prolapse in women evaluated with pelvic floor complaints. Methods: The data of 259 patients who applied to our hospital with pelvic floor complaints between May 2022 and March 2023 were evaluated retrospectively, and after the exclusion criteria were applied, the remaining 69 patients were included. Patients were grouped according to their primary complaints as those presenting with anterior compartment symptoms (ACS), those presenting with middle compartment symptoms (MCS), those presenting with posterior compartment symptoms (PCS), those presenting with proctological symptoms (PS) and those presenting with chronic pelvic pain (CPP). Results: A total of 69 patients were included in the study. The mean age was 49.8±13.1 years and the median symptom duration was 60 months. When patients are evaluated in terms of main complaint; The primary complaint was ACS in 16 patients, MCS in 4 patients, PCS in 26 patients, PS in 20 patients, and CPP in 3 patients. According to MRI defecography findings, ACS was detected in 1 patients, MCS in 1 patients, PCS in 13 patients and multicompartment prolapse in 54 patients. In patients with a history of vaginal delivery, in patients with a history of previous pelvic surgery and as the number of vaginal delivery increases multi-compartment prolapse rate was significantly increased. Conclusion: Regardless of the underlying primary complaint, the presence of multicompartment prolapse should be investigated through examination and tests in pelvic floor diseases. History and number of vaginal deliveries, previous pelvic surgery history carry a higher risk for multi-compartment prolapse.
- 27 May 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (3) , 337-340
Open AccessRelationship between pelvic floor complaints and multicompartment prolapsus
Aims: The aim of this study is to investigate the frequency and characteristics of multi-compartment prolapse in women evaluated with pelvic floor complaints. Methods: The data of 259 patients who applied to our hospital with pelvic floor complaints between May 2022 and March 2023 were evaluated retrospectively, and after the exclusion criteria were applied, the remaining 69 patients were included. Patients were grouped according to their primary complaints as those presenting with anterior compartment symptoms (ACS), those presenting with middle compartment symptoms (MCS), those presenting with posterior compartment symptoms (PCS), those presenting with proctological symptoms (PS) and those presenting with chronic pelvic pain (CPP). Results: A total of 69 patients were included in the study. The mean age was 49.8±13.1 years and the median symptom duration was 60 months. When patients are evaluated in terms of main complaint; The primary complaint was ACS in 16 patients, MCS in 4 patients, PCS in 26 patients, PS in 20 patients, and CPP in 3 patients. According to MRI defecography findings, ACS was detected in 1 patients, MCS in 1 patients, PCS in 13 patients and multicompartment prolapse in 54 patients. In patients with a history of vaginal delivery, in patients with a history of previous pelvic surgery and as the number of vaginal delivery increases multi-compartment prolapse rate was significantly increased. Conclusion: Regardless of the underlying primary complaint, the presence of multicompartment prolapse should be investigated through examination and tests in pelvic floor diseases. History and number of vaginal deliveries, previous pelvic surgery history carry a higher risk for multi-compartment prolapse.
- Open Access
- 1 September 2022
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 38 (3) , 250-254
The role of lower dose steroid therapy with vitamin D replacement in patients with idiopathic granulomatous mastitis
Objective: Low-dose steroid therapy has been recommended in idiopathic granulomatous mastitis (IGM) in various studies in the literature, but the therapeutic minimum dose has not been determined yet. Furthermore, vitamin D deficiency, the effect of which is accepted in autoimmune diseases, has not been previously examined in IGM. The aim of our study was to evaluate the efficacy of lower dose steroid theraphy with adjustment of vitamin D replacement doses with measuring serum 25-hydroxyvitamin D levels in patients with idiopathic granulomatous mastitis (IGM). Material and Methods: Vitamin D levels were evaluated in 30 IGM patients who applied to our clinic between 2017-2019. Vitamin D replacement was performed in patients with serum 25-hydroxyvitamin D level below 30 ng/mL and prednisolone was given to all patients at a dose of 0.05-0.1 mg/kg/ day. Clinical recovery times of the patients were compared with the literature. Results: Vitamin D replacement was given to 22 (73.33%) patients. Recovery time was shorter in patients receiving vitamin D replacement (7.62 ± 2.38; 9.00 ± 3.38; p= 0.680). Average recovery time was 8.00 ± 2.68 weeks. Conclusion: Treatment of IGM can be carried out with lower dose steroid therapy, leading to less complications and lower costs. Measuring serum 25-hydroxyvitamin D level and treating it with the appropriate dose may contribute to the healing process.
- 1 September 2022
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 38 (3) , 250-254
Open AccessThe role of lower dose steroid therapy with vitamin D replacement in patients with idiopathic granulomatous mastitis
Objective: Low-dose steroid therapy has been recommended in idiopathic granulomatous mastitis (IGM) in various studies in the literature, but the therapeutic minimum dose has not been determined yet. Furthermore, vitamin D deficiency, the effect of which is accepted in autoimmune diseases, has not been previously examined in IGM. The aim of our study was to evaluate the efficacy of lower dose steroid theraphy with adjustment of vitamin D replacement doses with measuring serum 25-hydroxyvitamin D levels in patients with idiopathic granulomatous mastitis (IGM). Material and Methods: Vitamin D levels were evaluated in 30 IGM patients who applied to our clinic between 2017-2019. Vitamin D replacement was performed in patients with serum 25-hydroxyvitamin D level below 30 ng/mL and prednisolone was given to all patients at a dose of 0.05-0.1 mg/kg/ day. Clinical recovery times of the patients were compared with the literature. Results: Vitamin D replacement was given to 22 (73.33%) patients. Recovery time was shorter in patients receiving vitamin D replacement (7.62 ± 2.38; 9.00 ± 3.38; p= 0.680). Average recovery time was 8.00 ± 2.68 weeks. Conclusion: Treatment of IGM can be carried out with lower dose steroid therapy, leading to less complications and lower costs. Measuring serum 25-hydroxyvitamin D level and treating it with the appropriate dose may contribute to the healing process.
- Open Access
- 8 January 2022
- Published by Academician Publishing
Meme Hastalıkları
Memenin Embriyolojisi ve Anatomisi Zekiye KARACA BOZDAĞ Buse Naz ÇANDIR Meme Hastalıklarında Patoloji Tuğçe BÖLME ŞAVLI Meme Radyolojisi Süleyman SÖNMEZ Mastodini Aziz OCAKOĞLU Hakan BÖLÜKBAŞI Selim Meme Hastalıkları Fadime Didem TRABULUS Hüsnü ŞEVİK Meme Kanserinde Korunma ve Tarama Stratejileri Yahya Kemal ÇALIŞKAN Meme Kanserinin Klinik Özellikleri, Tanı ve Evreleme Oğuzhan TEKİN Meme Kanserinde Sistemik Tedavi Yaklaşımları Sevinç DAĞIŞTANLI Meme Kanseri Tedavisinde Radyoterapi Yusuf BİLGİN Meme Kanserinin Cerrahi Tedavisi Berrin ÖNALAN Onkoplastik Meme Cerrahisi Tansu ALTINTAŞ Meme Kanserinde İzlem İsmail Hakkı Alp SOLAK
- 8 January 2022
- Published by Academician Publishing
Open AccessMeme Hastalıkları
Memenin Embriyolojisi ve Anatomisi Zekiye KARACA BOZDAĞ Buse Naz ÇANDIR Meme Hastalıklarında Patoloji Tuğçe BÖLME ŞAVLI Meme Radyolojisi Süleyman SÖNMEZ Mastodini Aziz OCAKOĞLU Hakan BÖLÜKBAŞI Selim Meme Hastalıkları Fadime Didem TRABULUS Hüsnü ŞEVİK Meme Kanserinde Korunma ve Tarama Stratejileri Yahya Kemal ÇALIŞKAN Meme Kanserinin Klinik Özellikleri, Tanı ve Evreleme Oğuzhan TEKİN Meme Kanserinde Sistemik Tedavi Yaklaşımları Sevinç DAĞIŞTANLI Meme Kanseri Tedavisinde Radyoterapi Yusuf BİLGİN Meme Kanserinin Cerrahi Tedavisi Berrin ÖNALAN Onkoplastik Meme Cerrahisi Tansu ALTINTAŞ Meme Kanserinde İzlem İsmail Hakkı Alp SOLAK
- 5 January 2022
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 122 (3) , 164-168
Effect of hyperthermic chemotherapy on topical hemostatic agents
There is no clear consensus as to which topical hemostatic agent is best used during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. The aim of this study was to evaluate the effect of hyperthermic chemotherapy on the biomechanical properties of organic topical hemostatic agents and histologically fibrin formation rates. Four topical hemostatic agents (Spongostan™, Surgicel®, Fibrillar™, Arista®) were evaluated. All agents were mixed with 3 ml blood in sterile tubes separately to form clot formation. The resulting clot formations were incubated with 36 °C and 42 °C with saline or cisplatin for 1 h. Strength and flexibility of hemostatic samples were evaluated under weight of 0 g, 50 g, 100 g, 200 g and 300 g. All samples were stained with hemotoxylin-eosin and compared histologically for fibrin clot formation under light microscope. There were no statistically significant differences according to strength and flexibility of topical hemostatic agents on hyperthermic chemotherapy. Histopathologically, the highest fibrin formation was observed in Surgicel®, followed by Fibrillar™. The least fibrin formation was detected in Arista®. This study demonstrated that exposure to hyperthermic chemotherapy did not significantly affect the biomechanical properties of organic topical hemostatic agents and the fibrin clot formation.
- 5 January 2022
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 122 (3) , 164-168
Effect of hyperthermic chemotherapy on topical hemostatic agents
There is no clear consensus as to which topical hemostatic agent is best used during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. The aim of this study was to evaluate the effect of hyperthermic chemotherapy on the biomechanical properties of organic topical hemostatic agents and histologically fibrin formation rates. Four topical hemostatic agents (Spongostan™, Surgicel®, Fibrillar™, Arista®) were evaluated. All agents were mixed with 3 ml blood in sterile tubes separately to form clot formation. The resulting clot formations were incubated with 36 °C and 42 °C with saline or cisplatin for 1 h. Strength and flexibility of hemostatic samples were evaluated under weight of 0 g, 50 g, 100 g, 200 g and 300 g. All samples were stained with hemotoxylin-eosin and compared histologically for fibrin clot formation under light microscope. There were no statistically significant differences according to strength and flexibility of topical hemostatic agents on hyperthermic chemotherapy. Histopathologically, the highest fibrin formation was observed in Surgicel®, followed by Fibrillar™. The least fibrin formation was detected in Arista®. This study demonstrated that exposure to hyperthermic chemotherapy did not significantly affect the biomechanical properties of organic topical hemostatic agents and the fibrin clot formation.